Current concepts of anti-EGFR targeting in metastatic colorectal cancer
Article in Frontiers in Oncology (November 2022)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
The Role of Anti-EGFR Monoclonal Antibody in mCRC Maintenance Therapy
Article in Frontiers in Molecular Biosciences (March 2022)
DPP3/CDK1 contributes to the progression of colorectal cancer through regulating cell proliferation, cell apoptosis, and cell migration
Article in Cell Death & Disease (May 2021)